The Alzheimer’s Foundation of America is holding a free one-day conference in Portland on Wednesday designed for patients, families and caregivers. One of the keynote speakers is Oregon Health and ...
Alzheimer’s disease affects millions of people around the world, slowly damaging memory, thinking, and behavior. For decades, scientists have searched for a way to stop or even slow down this ...
Discover how AI is reshaping Alzheimer’s and dementia care through early detection, faster clinical trials, and improved ...
Alzheimer’s disease is one of humanity’s most formidable foes. It affects 10 percent of people over age 65 and kills more people each year than breast cancer and prostate cancer combined. Its effects ...
In what researchers are calling an important scientific advance, a team in the US has shown through animal experiments that Alzheimer’s disease may be reversible, overturning a belief that has shaped ...
As an internal medicine doctor, I used to care for Alzheimer’s patients. Now, at just 60 years old, I am one. My diagnosis is not the future most people hope for — but there is finally a generation of ...
GLP-1s have been a breakthrough for obesity and diabetes. A 2022 study examined data from trials of GLP-1s in nearly 16,000 patients with diabetes, and showed that the drugs were associated with a 53% ...
The tests could help to improve dementia care, but scientists say there are still some caveats and unknowns. By Dana G. Smith Could a simple blood test predict your risk of getting dementia years, or ...
Frequent nightmares, or the inability to recall your dreams at all, could be early signs of Alzheimer's disease.
New data is showing a lower risk of Alzheimer's dementia in older adults who received high-dose flu shots compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results